Literature DB >> 9861081

Exercise testing in children with primary pulmonary hypertension.

R P Garofano1, R J Barst.   

Abstract

Cardiopulmonary exercise testing is a useful noninvasive tool to assess physiological changes associated with exercise. Developing noninvasive methods to assess the severity of cardiopulmonary disorders, as well as the response to therapeutic interventions, is useful in conditions, such as primary pulmonary hypertension, in which invasive procedures carry significant risks. The 6-minute walk test is a simple measure of exercise endurance. Exercise studies that measure both hemodynamic and ventilatory responses provide additional information regarding the interaction of the circulatory and pulmonary systems. Subtle changes in exercise capacity may suggest deterioration prior to clinical manifestations. This may lead to an earlier reevaluation, including repeat cardiac catheterization, and subsequently changes in medical and/or surgical therapy.

Entities:  

Mesh:

Year:  1999        PMID: 9861081     DOI: 10.1007/s002469900399

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Introduction: pediatric cardiology exercise testing.

Authors:  W B Strong
Journal:  Pediatr Cardiol       Date:  1999 Jan-Feb       Impact factor: 1.655

Review 2.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

3.  Response to bosentan in children with pulmonary hypertension.

Authors:  S Maiya; A A Hislop; Y Flynn; S G Haworth
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

4.  Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

Authors:  E B Rosenzweig; J A Feinstein; T Humpl; D D Ivy
Journal:  Prog Pediatr Cardiol       Date:  2009-12

5.  Non-invasive MR imaging techniques for measuring femoral arterial flow in a pediatric and adolescent cohort.

Authors:  Jessica E Caterini; Kate Rendall; Barbara Cifra; Jane E Schneiderman; Felix Ratjen; Mike Seed; Tammy Rayner; Ruth Weiss; Brian W McCrindle; Michael D Noseworthy; Craig A Williams; Alan R Barker; Gregory D Wells
Journal:  Physiol Rep       Date:  2022-05

Review 6.  Pulmonary Hypertension in Children.

Authors:  Dunbar Ivy
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

7.  Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension.

Authors:  Christopher M Rausch; Amy Lynne Taylor; Hayley Ross; Stefan Sillau; D Dunbar Ivy
Journal:  Int J Cardiol       Date:  2013-10-11       Impact factor: 4.164

Review 8.  Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.

Authors:  Benjamin S Frank; D Dunbar Ivy
Journal:  Children (Basel)       Date:  2018-03-23

9.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

10.  Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial.

Authors:  Stuart Russell; Maurice Beghetti; Ronald Oudiz; Cecile Balagtas; Min Zhang; Dunbar Ivy
Journal:  Open Heart       Date:  2019-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.